# Page 1
To extend the period for utilization of funds received from various sources during the financial year 2021-22 by transferring the same to the Purchase Cell under Haffkine Jeeva Pharmaceuticals Limited, Mumbai on short payment basis, pending payment of the earlier due details.
The Government of Maharashtra
the Department of Public Health
Government Resolution No: Purchase-2016/ PR No.240/ Part-1/ Health-8
10th Floor, Hospital Building
New Ministry, Mumbai- 400001.
Date is December 29, 2021.
Read: 1) Department of Public Health Government Decision No. 2016/ No. 240/ Health-8D. 07.03.2018.
(2) Department of Public Health No. Purchase-2016/ Q.No.240/ Part-1/ Health-8D. 04.01.2019.
3) Public Health Department Government Decision No. Purchase-2016/ P.S. No. 240/ Health-8D. 31.03.2020.
4) Public Health Department Government Decision No. Purchase-2016/ P.S. No. 240/ Health-8D. 28.12.2020.
5) Letter from the Director, Health Services, Pune No. Cess/ Director's Cell/ Withdrawal of funds on short payment/ extension/ Cell- 58/22338-41/ 2021 dated 03.10.2021
Director, Health Services, Pune. As per the proposal submitted on 03.10.2021, during the financial year 2021-22, the Government is considering to extend the period for utilization of funds received from various sources by transferring the same to the Purchase Cell under Haffkine Jeeva Drug Manufacturing Corporation, Mumbai on short payment basis, pending payment of the earlier details.
Government Decision: Reference No. Under Section 1, it was decided to set up a purchase cell under Haffkine Biopharma Corporation, Mumbai and transfer the budgetary funds for medicines, equipment, machinery and related items from 2017-18 to the purchase cell under Haffkine Corporation, Mumbai by making short payment. Reference No. Pending detailed payment of AC bills to the Public Health Department as permitted to the Home Department under Section 2, till alternative arrangements are made to draw funds on the second payment of AC bill (i.e.
# Page 2
Government Resolution No: Purchase-2016/ PR No.240/ Part-1/ Health-8
Approval was granted as a special case until a new accounting title was available for the purpose).
Reference No. The detailed payments under Section 3 were approved as a special case to be submitted to the Treasury by March, 2021. Reference No. During the financial year 2020-2021
The date for utilization of funds received for the said purpose from the sources was extended to 31st March, 2021 by transferring the same to Haffkine Jeeva Drug Manufacturing Corporation, Mumbai through short payment, pending payment of the earlier details.
However, since the lockdown, Epidemic Diseases Act was in force in the country due to COVID-19 pandemic since 23rd March, 2020, the Drawing and Disbursing Officer shall submit to the Treasury the details of funds drawn for the purchase of medicines, machinery, medical equipment, accessories and accessories on short payment for the financial years 2017-18, 2018-19, 2019-20 and 2020-21, subject to the condition that the funds received for the said purpose during the financial year 2021-22 through various sources shall be withdrawn on short payment pending payment of the previous detailed dues to Haffkine Jeeva Nirman Nigam Limited, Mumbai.
(3) The Commissionerate and the Corporation shall take care to submit to the Treasury the detailed payments by reconciling the amounts and the detailed payments in respect of the funds drawn from the Treasury by way of summary payments and shall also ensure that there are no accounting objections and that the amount is not misappropriated.
(4) This Government Decision, with the concurrence of the Department of Finance, in Informal Reference No. 341/2021/ Exchange, dated 29.11.2021.
# Page 3